|
1
|
Karak AK, Singh R, Tandon PN and Sarkar C:
A comparative survival evaluation and assessment of
interclassification concordance in adult supratentorial astrocytic
tumors. Pathol Oncol Res. 6:46–52. 2000.
|
|
2
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14(Suppl 5): v1–v49. 2012.
|
|
3
|
Dimova DK and Dyson NJ: The E2F
transcriptional network: old acquaintances with new faces.
Oncogene. 24:2810–2826. 2005.
|
|
4
|
Bracken AP, Ciro M, Cocito A and Helin K:
E2F target genes: unraveling the biology. Trends Biochem Sci.
29:409–417. 2004.
|
|
5
|
DeGregori J: The genetics of the E2F
family of transcription factors: shared functions and unique roles.
Biochim Biophys Acta. 1602:131–150. 2002.
|
|
6
|
Okamoto OK, Oba-Shinjo SM, Lopes L and
Nagahashi Marie SK: Expression of HOXC9 and E2F2 are up-regulated
in CD133(+) cells isolated from human astrocytomas and associate
with transformation of human astrocytes. Biochim Biophys Acta.
1769:437–442. 2007.
|
|
7
|
Galli R, Binda E, Orfanelli U, et al:
Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021.
2004.
|
|
8
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004.
|
|
9
|
Chen HZ, Tsai SY and Leone G: Emerging
roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev
Cancer. 9:785–797. 2009.
|
|
10
|
Murga M, Fernández-Capetillo O, Field SJ,
et al: Mutation of E2F2 in mice causes enhanced T lymphocyte
proliferation, leading to the development of autoimmunity.
Immunity. 15:959–970. 2001.
|
|
11
|
Chen D, Chen Y, Forrest D and Bremner R:
E2f2 induces cone photoreceptor apoptosis independent of E2f1 and
E2f3. Cell Death Differ. 20:931–940. 2013.
|
|
12
|
Opavsky R, Tsai SY, Guimond M, et al:
Specific tumor suppressor function for E2F2 in Myc-induced T cell
lymphomagenesis. Proc Natl Acad Sci USA. 104:15400–15405. 2007.
|
|
13
|
Fujiwara K, Yuwanita I, Hollern DP and
Andrechek ER: Prediction and genetic demonstration of a role for
activator E2Fs in Myc-induced tumors. Cancer Res. 71:1924–1932.
2011.
|
|
14
|
Strieder V and Lutz W: E2F proteins
regulate MYCN expression in neuroblastomas. J Biol Chem.
278:2983–2989. 2003.
|
|
15
|
Chen C and Wells AD: Comparative analysis
of E2F family member oncogenic activity. PLoS One. 2:e9122007.
|
|
16
|
Scheijen B, Bronk M, van der Meer T, De
Jong D and Bernards R: High incidence of thymic epithelial tumors
in E2F2 transgenic mice. J Biol Chem. 279:10476–10483. 2004.
|
|
17
|
Rode I and Boehm T: Regenerative capacity
of adult cortical thymic epithelial cells. Proc Natl Acad Sci USA.
109:3463–3468. 2012.
|
|
18
|
Li FX, Zhu JW, Hogan CJ and DeGregori J:
Defective gene expression, S phase progression, and maturation
during hematopoiesis in E2F1/E2F2 mutant mice. Mol Cell Biol.
23:3607–3622. 2003.
|
|
19
|
Dirlam A, Spike BT and Macleod KF:
Deregulated E2f-2 underlies cell cycle and maturation defects in
retinoblastoma null erythroblasts. Mol Cell Biol. 27:8713–8728.
2007.
|
|
20
|
Shen Q, Uray IP, Li Y, Krisko TI, Strecker
TE, Kim HT and Brown PH: The AP-1 transcription factor regulates
breast cancer cell growth via cyclins and E2F factors. Oncogene.
27:366–377. 2008.
|
|
21
|
Nguyen-Vu T, Vedin LL, Liu K, et al: Liver
X receptor ligands disrupt breast cancer cell proliferation through
an E2F-mediated mechanism. Breast Cancer Res. 15:R512013.
|
|
22
|
Dong Q, Meng P, Wang T, et al: MicroRNA
let-7a inhibits proliferation of human prostate cancer cells in
vitro and in vivo by targeting E2F2 and CCND2. PLoS One.
5:e101472010.
|
|
23
|
Lin PC, Chiu YL, Banerjee S, et al:
Epigenetic repression of miR-31 disrupts androgen receptor
homeostasis and contributes to prostate cancer progression. Cancer
Res. 73:1232–1244. 2013.
|
|
24
|
Yu SC, Ping YF, Yi L, et al: Isolation and
characterization of cancer stem cells from a human glioblastoma
cell line U87. Cancer Letters. 265:124–134. 2008.
|
|
25
|
Wu N, Xiao L, Zhao X, et al: miR-125b
regulates the proliferation of glioblastoma stem cells by targeting
E2F2. FEBS Lett. 586:3831–3839. 2012.
|
